🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Nutraceuticals & Cosmeceuticals

Benchmark revenue and EBITDA valuation multiples for public comps like Otsuka Holdings, Divi's Laboratories, Dermapharm, PharmaResearch and Zhangzhou Pientzehuang.

Nutraceuticals & Cosmeceuticals

See analyst estimates and all valuation multiples for Nutraceuticals & Cosmeceuticals
Company EV EV/Revenue EV/EBITDA
$25.4B 1.6x 6.9x
$20.1B 17.8x 55.6x
$17.0B 11.0x 33.3x
$9.4B 3.0x 7.3x
$7.2B 9.5x 35.6x
$6.8B 4.4x 22.6x
$4.1B 2.0x 13.3x
$3.6B n/a n/a
$3.1B 2.3x 8.7x
$3.1B 10.3x 25.5x
$3.0B 1.4x 8.2x
$2.3B 7.8x 15.5x
$1.6B 6.8x 26.5x
$1.6B n/a n/a
$1.3B 1.1x 4.5x
$1.3B 2.3x 11.7x
$1.1B 8.2x 30.7x
$1.1B n/a n/a
$1.0B n/a n/a
$905M 6.0x 17.9x
$876M 3.5x 9.1x
$667M n/a n/a
$560M 1.2x 5.9x
$541M n/a n/a
$539M 10.9x 30.6x
$531M 3.9x 14.5x
$240M 3.5x n/a
$144M 2.2x 10.0x
$101M n/a n/a
$33.2M n/a n/a
$22.0M 0.9x -257.5x
$15.8M n/a n/a
$15.0M n/a n/a
$14.5M 7.5x -1.3x
$7.5M n/a n/a
$4.1M n/a n/a
$2.0M n/a n/a
-$3.5M n/a n/a

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Nutraceuticals & Cosmeceuticals

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.